SARS-CoV-2 involvement in central nervous system tissue damage
Loading...
Files
Date
Journal Title
Journal ISSN
Volume Title
Publisher
Wolters Kluwer Medknow Publications
Abstract
As the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to spread globally, it became evident that the SARS-CoV-2 virus infects multiple organs including the brain. Several clinical studies revealed that patients with COVID-19 infection experience an array of neurological signs ranging in severity from headaches to life-threatening strokes. Although the exact mechanism by which the SARS-CoV-2 virus directly impacts the brain is not fully understood, several theories have been suggested including direct and indirect pathways induced by the virus. One possible theory is the invasion of SARS-CoV-2 to the brain occurs either through the bloodstream or via the nerve endings which is considered to be the direct route. Such findings are based on studies reporting the presence of viral material in the cerebrospinal fluid and brain cells. Nevertheless, the indirect mechanisms, including blood-clotting abnormalities and prolonged activation of the immune system, can result in further tissue and organ damages seen during the course of the disease. This overview attempts to give a thorough insight into SARS-CoV-2 coronavirus neurological infection and highlights the possible mechanisms leading to the neurological manifestations observed in infected patients. © 2022 Wolters Kluwer Medknow Publications. All rights reserved.
Description
Keywords
Autoantibodies, Cns infection, Coagulopathy, Covid-19, Encephalitis, Neuroinflammation, Renin-angiotensin system, Viral encephalopathy, Angiotensin converting enzyme 2, Angiotensinogen, Autoantibody, Bilirubin, Cathepsin l, Cytokine, Dexmedetomidine, Gamma interferon, Immunoglobulin enhancer binding protein, Inflammasome, Interleukin 18, Interleukin 1beta, Interleukin 6, Interleukin 8, Kallidin, Lipocortin 2, Neuropilin 1, Nitric oxide, Purinergic p2x receptor, Purinergic p2x7 receptor, Reactive oxygen metabolite, Rituximab, Toll like receptor 4, Tumor necrosis factor, Vascular cell adhesion molecule 1, Adaptive immunity, Adult respiratory distress syndrome, Alzheimer disease, Autoimmunity, Blood clotting disorder, Brain blood flow, Brain cell, Brain damage, Brain hemorrhage, Brain tissue, Central nervous system, Central nervous system infection, Cerebrospinal fluid, Cerebrovascular accident, Controlled study, Coronavirus disease 2019, Cytokine production, Electroencephalography, Endothelial dysfunction, Epilepsy, Headache, Hippocampus, Human, Immune response, Immunostimulation, Innate immunity, Kallikrein kinin system, Microglia, Mouse, Nerve cell plasticity, Nerve degeneration, Nerve regeneration, Nervous system inflammation, Nonhuman, Oxidative stress, Parkinsonism, Protein expression, Prothrombin time, Pyroptosis, Renin angiotensin aldosterone system, Review, Sars coronavirus, Severe acute respiratory syndrome coronavirus 2, Tissue injury, Virus replication